|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,437.00 JPY | +0.19% |
|
-0.93% | +2.35% |
| 12-30 | Chugai Completes Merger With Renalys Pharma | MT |
| 12-29 | Chugai Pharmaceutical Co., Ltd. completed the acquisition of Renalys Pharma. | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | JP¥8,764.29 | +4.08% | 14 | ||||||
| US$1,116.33 | +3.27% | 27 | ||||||
| US$212 | +1.09% | 24 | ||||||
| US$244.59 | +11.16% | 27 | ||||||
| CHF 331.47 | -3.22% | 17 | ||||||
| GBX 203.79 | +7.15% | 19 | ||||||
| US$113.33 | +3.79% | 27 | ||||||
| CHF 137.35 | -3.92% | 19 | ||||||
| DKK 392.29 | +3.48% | 20 | ||||||
| US$330.41 | +1.5% | 27 | ||||||
| US$134.19 | +9.45% | 26 | ||||||
| US$28.66 | +13.4% | 24 | ||||||
| €102.77 | +24.71% | 21 | ||||||
| US$500.4 | +8.64% | 25 | ||||||
| US$56.57 | +1.43% | 23 | ||||||
| GBX 18.84 | +0.38% | 18 | ||||||
| CN¥82.86 | +29.78% | 17 | ||||||
| US$493.28 | +32.99% | 25 | ||||||
| JP¥4,960.43 | -2.35% | 14 | ||||||
| Average | 959.15 | +7.73% | 22 | ||||||
| Weighted average by Cap. | 632.46 | +4.72% | 23 |
- Stock Market
- Equities
- 4519 Stock
- Sector Chugai Pharmaceutical Co., Ltd.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition